ÃÛÌÒÊÓƵ

Authenticating with LexisNexis

Try our Advanced Search for more refined results

IN RE: GENERIC PHARMACEUTICALS PRICING ANTITRUST LITIGATION

Track this case

Case overview

Case Number:

2:16-md-02724

Court:

Pennsylvania Eastern

Nature of Suit:

Other Statutes: Anti-Trust

Multi Party Litigation:

Class Action, Multi-district Litigation

Judge:

CYNTHIA M. RUFE

Firms

Companies

Government Agencies

Sectors & Industries:

  1. March 13, 2023

    Pharma Cos. Say Civil Evidence Off Limits In Criminal Case

    Pharmaceutical companies that have been facing multidistrict litigation over price-fixing claims are saying absolutely not to an attempt by the U.S. Department of Justice to access civil discovery materials for use in criminal prosecutions tied to the alleged scheme.

  2. March 10, 2023

    Generic Drug Buyers Get $75M In Price-Fixing Deals Approved

    A Pennsylvania federal court signed off on settlements ending price-fixing claims from direct purchasers against Sun Pharmaceutical Industries Inc. and Taro Pharmaceutical Industries USA Inc. in ongoing multidistrict litigation over generic drug prices.

  3. February 27, 2023

    Drugmakers To Face Price-Fixing Claims From State AGs

    In a slew of rulings on Monday, a Pennsylvania federal court rejected most bids from drug companies seeking to nix sweeping price-fixing conspiracy allegations from a group of state attorneys general.

  4. November 09, 2022

    Drug Buyers, States Want To Depose Indicted Ex-Taro Exec

    A group of drug purchasers and state-level enforcers accusing generic-drug manufacturers of fixing prices asked a Pennsylvania federal court on Tuesday to allow it to depose a former top executive who was indicted on criminal antitrust charges ahead of his trial.

  5. June 07, 2022

    AGs' Disgorgement Claim Axed In Drug Price-Fixing Case

    The Pennsylvania federal judge overseeing sprawling price-fixing litigation against generic-drug makers on Tuesday tossed a disgorgement claim brought by state attorneys general, but kept alive their claim for injunctive relief.

  6. May 25, 2022

    Generic Distributors Slip Indirect Reseller Price-Fixing Claims

    A Pennsylvania federal judge dismissed, for now, indirect generic-drug resellers' price-fixing claims levied against distributors like McKesson Corp. as a part of multidistrict litigation, ruling Wednesday that the plaintiffs failed to sufficiently allege a conspiracy.

  7. May 20, 2022

    Drugmakers Say Pa. AG Not Producing Generic-Drug Docs

    Mylan and other pharmaceutical companies facing allegations of price-fixing for generic drugs told a Pennsylvania federal judge overseeing multidistrict litigation that the Pennsylvania Attorney General's Office has refused to produce key documents.

  8. May 11, 2022

    Settlements Worth $86M OK'd In Drug Price-Fixing MDL

    Deals for three generic-drug companies to fork over a combined $86 million to direct purchasers and indirect resellers to settle price-fixing allegations gained preliminary approval from a Philadelphia federal judge Wednesday.

  9. May 10, 2022

    End-Payor State Claims Stick In Generic Drug Price-Fix MDL

    A Pennsylvania federal court denied a dismissal bid Tuesday from drug companies in sprawling multidistrict litigation over alleged generic drug price-fixing, refusing to toss some state claims from end-payors while rejecting arguments that intervening authority should result in the claims being nixed.

  10. April 07, 2022

    Teva Appears Headed For $100M Price-Fixing Payout To AGs

    After last week's $1.45 million settlement with Louisiana's attorney general, a pattern is emerging in Teva's efforts to deal its way out of sprawling price-fixing litigation that could put the generic-drug maker on the hook for about $100 million if it settles with every state enforcer.